Clarification on the news article by United Daily News E-Paper
Date of occurrence of the event: January 11, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A …
OBI Pharma Deeply Disappointed with Prosecutor’s Decision to Proceed with Cases. Facts should demonstrate Innocence.
OBI Pharma Deeply Disappointed with Prosecutor’s Decision to Proceed with Cases. Facts should demonstrate Innocence. Shi-Lin District prosecutors Office announced today (9 Jan 2017) the result of the investigation of …
Clarification on the news article by Economic Daily News
Date of occurrence of the event: January 10, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A …
Press release by the Shihlin District Prosecutors Office, Taiwan
Date of occurrence of the event: January 9, 2017 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A …
Announcement of the signing of a Non-Binding Letter of Intent for OBI Pharma, Inc., to issue new shares to AbProtix, Inc., in exchange for up to 70% stake in AP Biosciences
DATE OF THE EVENT: 30 December 2016 COUNTERPARTY TO THE CONTRACT OR COMMITMENT: AbProtix Inc., a company registered in the Cayman Islands. RELATIONSHIP TO THE COMPANY: None STARTING AND ENDING …
Clarification on the news article by Economic Daily News
1.Date of occurrence of the event: December 22, 2016 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A 4.Reciprocal shareholding ratios: N/A …
OBI Pharma Awarded Level-A Recognition for TIPS Management
OBI Pharma, Taiwan (4174) announced that it has been awarded a “Level-A” rating by auditors from the government-sponsored TIPS (Taiwan Intellectual Property Management System) project, in recognition of the quality …
OBI Pharma granted patent approval for its 2nd Generation Active Immunotherapy Treatment by Taiwan and Australia
1.Date of occurrence of the event: 23 Nov 2016 2.Company name: OBI Pharma 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head Office 4.Reciprocal shareholding ratios: N/A 5.Cause …
OBI Pharma Granted OBI 833 Patents for Taiwan and Australia
OBI Pharma, Taiwan (4174) announced that it has been granted Taiwan and Australian patents protecting OBI-833, its new cancer vaccine comprised of the Globo H hexasaccharide (Globo H) antigen conjugated …
Clarification on the news article by Economic Daily News E-Paper
1.Date of occurrence: November 04, 2016 2.Company name: OBI Pharma, Inc. 3.Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A 4.Reciprocal shareholding ratios: N/A 5.Name of mass …